FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2741728478> ?p ?o ?g. }

• W2741728478 endingPage "e0181757" @default.
• W2741728478 startingPage "e0181757" @default.
• W2741728478 abstract "The aim of this study was to assess any potential additive effects of a treatment combining aliskiren with paricalcitol on reducing renal fibrosis. C57BL/6J mice were treated individually with aliskiren and/or paricalcitol until 7 days after initiation of unilateral ureteral obstruction (UUO).In obstructed kidneys of UUO mice, monotherapy with aliskiren or paricalcitol significantly attenuated interstitial fibrosis, collagen IV accumulation, and α-smooth muscle actin- and terminal deoxynucleotidyl transferase-mediated biotin nick end-labeling-positive cells. The combination treatment showed additive efficacy in inhibition of these parameters. Renal NADPH oxidase (Nox)1 and Nox2 were significantly decreased by aliskiren or paricalcitol alone or in combination, while renal Nox4 expression was significantly reduced by paricalcitol mono- or combination treatment. Increased levels of p-Erk and p-p38 MAPK, and NF-κB in UUO kidneys were also significantly reduced by either aliskiren or paricalcitol treatment alone or in combination. Aliskiren or paricalcitol monotherapy significantly reduced the expression of (pro)renin receptor in UUO kidneys. In addition, aliskiren tended to augment renin expression in UUO kidneys, but paricalcitol reduced its expression level. The combination treatment effectively blocked both (pro)renin receptor and renin expression induced by aliskiren, and resulted in a further reduction of the renal expression of angiotensin II AT1 receptor. Aliskiren failed to increase the expression of vitamin D receptor in UUO kidneys, but the combination treatment restored its expression level. Taken together, a treatment combining aliskiren with paricalcitol better inhibits UUO-induced renal injury. The mechanism of this synergy may involve more profound inhibition of the intrarenal renin-angiotensin system." @default.
• W2741728478 created "2017-08-08" @default.
• W2741728478 creator A5011073372 @default.
• W2741728478 creator A5018938074 @default.
• W2741728478 creator A5028514834 @default.
• W2741728478 creator A5029366589 @default.
• W2741728478 creator A5033725654 @default.
• W2741728478 creator A5034892664 @default.
• W2741728478 creator A5062071515 @default.
• W2741728478 creator A5065254353 @default.
• W2741728478 date "2017-07-28" @default.
• W2741728478 modified "2023-09-23" @default.
• W2741728478 title "Treatment combining aliskiren with paricalcitol is effective against progressive renal tubulointerstitial fibrosis via dual blockade of intrarenal renin" @default.
• W2741728478 cites W1966068198 @default.
• W2741728478 cites W1982280466 @default.
• W2741728478 cites W1983456891 @default.
• W2741728478 cites W1983589399 @default.
• W2741728478 cites W1986715869 @default.
• W2741728478 cites W1989851827 @default.
• W2741728478 cites W1999636472 @default.
• W2741728478 cites W2001962405 @default.
• W2741728478 cites W2007173756 @default.
• W2741728478 cites W2008494063 @default.
• W2741728478 cites W2019223764 @default.
• W2741728478 cites W2020876708 @default.
• W2741728478 cites W2035357682 @default.
• W2741728478 cites W2036960544 @default.
• W2741728478 cites W2040181550 @default.
• W2741728478 cites W2049491194 @default.
• W2741728478 cites W2067006074 @default.
• W2741728478 cites W2069297049 @default.
• W2741728478 cites W2095544263 @default.
• W2741728478 cites W2105235416 @default.
• W2741728478 cites W2116079133 @default.
• W2741728478 cites W2117048312 @default.
• W2741728478 cites W2120416165 @default.
• W2741728478 cites W2133750359 @default.
• W2741728478 cites W2135910107 @default.
• W2741728478 cites W2136083733 @default.
• W2741728478 cites W2139181447 @default.
• W2741728478 cites W2148121678 @default.
• W2741728478 cites W2159120963 @default.
• W2741728478 cites W2159671326 @default.
• W2741728478 cites W2168828068 @default.
• W2741728478 cites W2170783508 @default.
• W2741728478 cites W2234530332 @default.
• W2741728478 cites W2256903816 @default.
• W2741728478 cites W2282519168 @default.
• W2741728478 cites W2324185252 @default.
• W2741728478 cites W2418696034 @default.
• W2741728478 cites W2515348093 @default.
• W2741728478 cites W2516192381 @default.
• W2741728478 cites W2520090697 @default.
• W2741728478 cites W2552364718 @default.
• W2741728478 cites W2560790523 @default.
• W2741728478 cites W2563128527 @default.
• W2741728478 doi "https://doi.org/10.1371/journal.pone.0181757" @default.
• W2741728478 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5929502" @default.
• W2741728478 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29715294" @default.
• W2741728478 hasPublicationYear "2017" @default.
• W2741728478 type Work @default.
• W2741728478 sameAs 2741728478 @default.
• W2741728478 citedByCount "16" @default.
• W2741728478 countsByYear W27417284782018 @default.
• W2741728478 countsByYear W27417284782019 @default.
• W2741728478 countsByYear W27417284782020 @default.
• W2741728478 countsByYear W27417284782021 @default.
• W2741728478 countsByYear W27417284782022 @default.
• W2741728478 countsByYear W27417284782023 @default.
• W2741728478 crossrefType "journal-article" @default.
• W2741728478 hasAuthorship W2741728478A5011073372 @default.
• W2741728478 hasAuthorship W2741728478A5018938074 @default.
• W2741728478 hasAuthorship W2741728478A5028514834 @default.
• W2741728478 hasAuthorship W2741728478A5029366589 @default.
• W2741728478 hasAuthorship W2741728478A5033725654 @default.
• W2741728478 hasAuthorship W2741728478A5034892664 @default.
• W2741728478 hasAuthorship W2741728478A5062071515 @default.
• W2741728478 hasAuthorship W2741728478A5065254353 @default.
• W2741728478 hasBestOaLocation W27417284781 @default.
• W2741728478 hasConcept C126322002 @default.
• W2741728478 hasConcept C126894567 @default.
• W2741728478 hasConcept C134018914 @default.
• W2741728478 hasConcept C170493617 @default.
• W2741728478 hasConcept C179639408 @default.
• W2741728478 hasConcept C198710026 @default.
• W2741728478 hasConcept C2776999253 @default.
• W2741728478 hasConcept C2777425892 @default.
• W2741728478 hasConcept C2778838027 @default.
• W2741728478 hasConcept C2779524405 @default.
• W2741728478 hasConcept C2779838083 @default.
• W2741728478 hasConcept C2780559512 @default.
• W2741728478 hasConcept C2781208988 @default.
• W2741728478 hasConcept C519063684 @default.
• W2741728478 hasConcept C71924100 @default.
• W2741728478 hasConcept C84393581 @default.
• W2741728478 hasConcept C98274493 @default.
• W2741728478 hasConceptScore W2741728478C126322002 @default.
• W2741728478 hasConceptScore W2741728478C126894567 @default.

• next